Benzinga | May 4, 2021 07:20AM EDT

Seres Therapeutics Q1 EPS $(0.39) Misses $(0.31) Estimate, Sales $5.72M Miss $6.45M Estimate

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.31) by 25.81 percent. This is a 39.29 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $5.72 million which missed the analyst consensus estimate of $6.45 million by 11.35 percent. This is a 30.17 percent decrease over sales of $8.19 million the same period last year.